Neuren Pharmaceuticals (ASX:NEU) Share Price and News - StockTrack

Market Cap (1-Jul) $1,753,780,864 (454th)	Close (30-Jun) $12.25 0 (0%)	Volume (30-Jun) 261,029	Shortsold (19-Jun) 7,497,069 (6.03%) (29th)
52w High $22.44	52w Low $8.61	P/E 84.03	EPS 1.09

	Subject
	NEU NEU Ann: Change in substantial holding
	1 (current) 2 3
	NEU NEU Ann: Appendix 4G
	NEU NEU Ann: Annual Report to shareholders
	NEU NEU Ann: FDA approval for Pitt Hopkins syndrome IND and Phase 2 trial
	NEU NEU Ann: FDA approval for Phelan-McDermid IND and Phase 2 trial
	NEU NEU Ann: Ethics approval for Angelman Phase 2 trial in Australia
	NEU NEU Ann: S&P DJI Announces March 2022 Quarterly Rebalance
	NEU NEU Ann: Investor presentation 25 Feb 2022
	NEU NEU Ann: FDA approval for Angelman IND and Phase 2 trial
	NEU NEU Ann: 2021 Results - a transformational year for Neuren
	NEU NEU Ann: Preliminary Final Report and 2021 Full Year Accounts
	NEU NEU Ann: Notification regarding unquoted securities - NEU
	NEU NEU Ann: Neuren appoints Vice President, Corporate Development
	NEU NEU Ann: Q4 2021 quarterly activity and cash flow report
	NEU NEU Ann: Becoming a substantial holder
	NEU NEU Ann: Positive topline results from Phase 3 trial in Rett syndrome
	NEU NEU Ann: Neuren presenting at Bell Potter Healthcare Conference
	NEU NEU Ann: Q3 2021 quarterly activity and cash flow report
	NEU NEU Ann: Neuren receives feedback on IND for Phelan-McDermid syndrome
	NEU NEU Ann: Change of Director's Interest Notice - D Angus
	NEU NEU Ann: US patent to 2034 granted for Neuren's NNZ-2591 in autism
	NEU NEU Ann: Change of Director's Interest Notice - J Harry
	NEU NEU Ann: Change of Director's Interest Notice - J Pilcher
	NEU NEU Ann: Change of Director's Interest Notice - P Davies
	NEU NEU Ann: Application for quotation of securities - NEU
	NEU NEU Ann: Update - Proposed issue of securities - NEU
	NEU NEU Ann: $3.3 million raised from oversubscribed SPP
	NEU NEU Ann: Feedback on Angelman IND and submission of Pitt Hopkins IND
	NEU NEU Ann: IND application submitted for NNZ-2591 in Phelan-McDermid
	NEU NEU Ann: Share Purchase Plan Offer Booklet
	NEU NEU Ann: Section 708A Notice
	NEU NEU Ann: New patent issued to 2032 for Neuren's trofinetide in Brazil
	NEU NEU Ann: Application for quotation of securities - NEU
	NEU NEU Ann: Investor Presentation, 13 September 2021
	NEU NEU Ann: Proposed issue of securities - NEU
	NEU NEU Ann: Placement to accelerate NNZ-2591 across 4 indications
	NEU NEU Ann: Notification of investor presentation, 9.00 AEST 13 Sept 21
	NEU NEU Ann: Trading Halt
	NEU NEU Ann: FDA grants Orphan Drug designation for Prader-Willi syndrome
	NEU NEU Ann: Angelman IND and Ethics applications submitted for NNZ-2591
	NEU NEU Ann: Trofinetide Rett syndrome clinical trial in girls aged 2-5
	NEU NEU Ann: R&D Tax Incentive Advance Overseas Finding Approval
	NEU NEU Ann: Half-year shareholder update
	NEU NEU Ann: Half Yearly Report and Accounts
	NEU NEU Ann: Notification of investor webinar
	NEU NEU Ann: Phase 3 enrolment successfully completed, results in Q4 2021
	NEU NEU Ann: Q2 2021 quarterly activity and cash flow report
	NEU NEU Ann: Change of Director's Interest Notice
	NEU NEU Ann: Results of Meeting
	NEU NEU Ann: AGM Chairman's Address and CEO Presentation

Similar Companies

Cann Group

CAN

Creso Pharma

CPH

Ecofibre

EOF

Incannex Healthcare

IHL

Medical Developments International

MVP

Mayne Pharma Group

MYX

Probiotec

PBP

Recce Pharmaceuticals Ltd

RCE

Starpharma Holdings

SPL

End of Day Prices

Date	Close	Volume	Change
30-Jun	$14.11	438,022	-0.09 (0.63%)
27-Jun	$14.20	655,847	+0.89 (6.69%)
26-Jun	$13.31	1,453,659	+0.77 (6.14%)
24-Jun	$12.54	652,167	+0.28 (2.28%)
23-Jun	$12.26	571,564	-0.28 (2.23%)
20-Jun	$12.54	885,608	+0.10 (0.80%)
19-Jun	$12.44	509,534	-0.48 (3.72%)
18-Jun	$12.92	616,166	-0.04 (0.31%)
16-Jun	$12.96	428,882	-0.14 (1.07%)
13-Jun	$13.10	725,687	-0.80 (5.76%)
12-Jun	$13.90	311,893	+0.14 (1.02%)
06-Jun	$13.76	251,566	-0.14 (1.01%)
05-Jun	$13.90	322,479	0.00 (0.00%)
04-Jun	$13.90	485,435	+0.19 (1.39%)
03-Jun	$13.71	308,105	+0.14 (1.03%)
7 up, 7 down, and 1 flat days

High $12.50	Low $12.07	Trades 2,722	Turnover $3,205,258	Volume 261,029
30 June 2023 at 4:55pm

High $12.50	Low $12.07	Trades 2,722	Turnover $3,205,258	Volume 261,029
30 June 2023 at 4:55pm

Neuren Pharmaceuticals Health Care

$12.25 -0.23 (-1.84%)

$12.25 -0.23 (-1.84%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices